Clinical Scorecard: ESCMID Global 2026: Faster Diagnostics at What Cost?

At a Glance

Key Highlights

• Rapid diagnostics can shorten time to result but may not improve outcomes without aligned clinical pathways.
• Emerging technologies include ultra-rapid nanoplasmonic colorimetry and AI-integrated platforms.
• Regulatory convergence is essential for the safe adoption of new diagnostic tools.

Guideline-Based Recommendations

Diagnosis

• Utilize rapid diagnostics while ensuring quality and integration into clinical workflows.

Management

• Implement antimicrobial stewardship alongside rapid diagnostic tools.

Monitoring & Follow-up

• Regularly validate new diagnostic approaches to ensure reliability.

Risks

• Faster tests may create bottlenecks if not properly integrated into existing systems.

Patient & Prescribing Data

Neonates and patients with suspected infections or AMR

Timely and accurate susceptibility data is crucial for effective treatment.

Clinical Best Practices

• Maintain quality in diagnostics despite the push for speed.
• Collaborate closely with clinical teams to ensure diagnostic advances lead to better patient outcomes.
• Adopt a One Health perspective in diagnostics, considering human, animal, and environmental health.

References

• ESCMID Global 2026 Conference